Welcome back to the Class Action & MDL Roundup!
This edition covers notable class actions from the second quarter of 2023. In this edition, essential oils may need therapy, an ever-growing library goes nowhere, and one exclusion is specifically ambiguous. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
We wrap up the Roundup with a summary of class action settlements finalized in the second quarter.
Please see full publication below for more information.